1. Home
  2. |Insights
  3. |Energy Efficiency and Renewable Energy Contracting

Energy Efficiency and Renewable Energy Contracting

Client Alert | less than 1 min read | 05.28.09

In Doing Business with the Government in 2009: New Opportunities for Energy Efficiency and Renewable Energy Contracting in the May 2009 issue of Bloomberg Sustainable Energy Law Reports, J. Catherine Kunz and Steve McBrady of Crowell & Moring examine the federal government's unprecedented investment in renewable energy infrastructure and related research and development via the recently passed American Recovery and Reinvestment Act (ARRA). This substantial federal commitment will generate increased business opportunities for government contractors in energy efficient technology, renewable energy, energy infrastructure, and related fields; however, contractors must be aware that contracting under the ARRA will also require compliance with new regulations and a number of new oversight and reporting requirements.

Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights